|
| 34337191 | Lowâ¿¿Level Environmental Heavy Metals are Associated with Obesity Among Postmenopausal Women in a Southern State. | Exposure and Health | 2021 |
| 32582547 | Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study. | Frontiers in Oncology | 2020 |
| 32298288 | Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer. | PLoS ONE | 2020 |
| 31537196 | Development and Evaluation of a Blood Glucose Monitoring YouTube Video for Marshallese Patients Using a Community-Based Participatory Research Approach. | Policy, Politics, and Nursing Practice | 2019 |
| 31579384 | Mobile Mammography Screening as an Opportunity to Increase Access of Rural Women to Breast Cancer Research Studies. | Breast Cancer: Basic and Clinical Research | 2019 |
| 35117114 | Association between breast cancer risk and leisure physical activity in a rural cohort population. | Translational Cancer Research | 2019 |
| 35117111 | Individual- and county-level determinants of high breast cancer incidence rates. | Translational Cancer Research | 2019 |
| 35116801 | County poverty levels influence genome-wide DNA methylation profiles in African American and European American women. | Translational Cancer Research | 2019 |
| 30928413 | Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study. | Clin Breast Cancer | 2019 |
| 28084139 | A high frequency missense SULT1B1 allelic variant (L145V) selectively expressed in African descendants exhibits altered kinetic properties. | Xenobiotica | 2018 |
| 30281645 | Validation of a genetic risk score for Arkansas women of color. | PLoS ONE | 2018 |
| 29760829 | Challenges in recruiting African-American women for a breast cancer genetics study. | Hereditary Cancer in Clinical Practice | 2018 |
| 29205500 | A functional SNP in the 3'-UTR of TAP2 gene interacts with microRNA hsa-miR-1270 to suppress the gene expression. | Environmental and Molecular Mutagenesis | 2018 |
| 28045923 | Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. | PLoS ONE | 2017 |
| 28689351 | Leveraging community-based participatory research capacity to recruit Pacific Islanders into a genetics study. | Journal of Community Genetics | 2017 |
| 27797121 | Change in Mammography Use Following the Revised Guidelines from the U.S. Preventive Services Task Force. | Breast Journal | 2017 |
| 24577164 | High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer. | American Journal of Clinical Oncology: Cancer Clinical Trials | 2016 |
| 27547236 | 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer. | Nutrition and Metabolism | 2016 |
| 25996841 | Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines. | Cancer Biology and Therapy | 2015 |
| 25704921 | Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. | Scientific Reports | 2015 |
| 25823469 | Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells. | Oncology Reports | 2015 |
| 25647083 | Genotypic and allelic variability in CYP19A1 among populations of African and European ancestry. | PLoS ONE | 2015 |
| 26985457 | Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples. | | 2015 |
| 26428001 | Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells. | Biochemical Pharmacology | 2015 |
| 24917585 | A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives. | Drug Metabolism and Disposition | 2014 |
| 25493573 | Pharmacogenetics of SULT1A1. | Pharmacogenomics | 2014 |
| 24393253 | Sulfotransferase 1A1 (SULT1A1) gene expression is regulated by members of the NFI transcription factors in human breast cancer cells. | BMC Clinical Pathology | 2014 |
| 25200109 | Cross-sectional study to assess the association of population density with predicted breast cancer risk. | Breast Journal | 2014 |
| 25114581 | CYP19A1 single nucleotide polymorphism associations with CYP19A1, NFκB1, and IL6 gene expression in human normal colon and normal liver samples. | Pharmacogenomics and Personalized Medicine | 2014 |
| 22121102 | JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. | Molecular Carcinogenesis | 2013 |
| 22674296 | Interleukin genes and associations with colon and rectal cancer risk and overall survival. | International Journal of Cancer | 2013 |
| 24298433 | Fulvestrant up regulates UGT1A4 and MRPs through ERα and c-Myb pathways: a possible primary drug disposition mechanism. | SpringerPlus | 2013 |
| 24101876 | Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue. | Pharmacogenomics and Personalized Medicine | 2013 |
| 24142574 | Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects. | Journal of Surgical Oncology | 2013 |
| 24010997 | Sulfotransferase genetic variation: from cancer risk to treatment response. | Drug Metabolism Reviews | 2013 |
| 23526707 | Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects. | Pharmacogenomics and Personalized Medicine | 2013 |
| 23526580 | GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer. | Pharmacogenomics and Personalized Medicine | 2013 |
| 23371966 | Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics. | Drug Metabolism and Disposition | 2013 |
| 22260523 | Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. | BMC Cancer | 2012 |
| 22593037 | Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity. | Drug Metabolism and Disposition | 2012 |
| 22434874 | Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics. | Drug Metabolism and Disposition | 2012 |
| 23050053 | Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer. | International Journal of Molecular Epidemiology and Genetics (discontinued) | 2012 |
| 23080433 | Differential promoter activities of functional haplotypes in the 5'-flanking region of human sulfotransferase 1A1. | Journal of Biochemical and Molecular Toxicology | 2012 |
| 21387313 | Genetic variation in bone morphogenetic protein and colon and rectal cancer. | International Journal of Cancer | 2012 |
| 21538574 | Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. | Molecular Carcinogenesis | 2011 |
| 22822301 | Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1. | Pharmacogenomics and Personalized Medicine | 2011 |
| 21489034 | Establishment of a southern breast cancer cohort. | Breast Journal | 2011 |
| 21479914 | Variation in the CYP19A1 gene and risk of colon and rectal cancer. | Cancer Causes and Control | 2011 |
| 21637860 | Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. | PLoS ONE | 2011 |
| 21822452 | Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation. | Hormone Molecular Biology and Clinical Investigation | 2010 |